Ignite Creation Date:
2025-12-25 @ 4:33 AM
Ignite Modification Date:
2026-03-03 @ 2:19 PM
Study NCT ID:
NCT04523818
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-29
First Post:
2020-08-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Clinical Stage I Gastric Cancer AJCC v8 | View |
| None | Clinical Stage IIA Gastric Cancer AJCC v8 | View |
| None | Clinical Stage III Gastric Cancer AJCC v8 | View |
| None | Clinical Stage IVA Gastric Cancer AJCC v8 | View |
| None | Gastric Adenocarcinoma | View |
| None | Pathologic Stage IB Gastric Cancer AJCC v8 | View |
| None | Pathologic Stage II Gastric Cancer AJCC v8 | View |
| None | Pathologic Stage IIA Gastric Cancer AJCC v8 | View |
| None | Pathologic Stage IIB Gastric Cancer AJCC v8 | View |
| None | Pathologic Stage III Gastric Cancer AJCC v8 | View |
| None | Pathologic Stage IIIA Gastric Cancer AJCC v8 | View |
| None | Pathologic Stage IIIB Gastric Cancer AJCC v8 | View |
| None | Pathologic Stage IIIC Gastric Cancer AJCC v8 | View |
| None | Postneoadjuvant Therapy Stage I Gastric Cancer AJCC v8 | View |
| None | Postneoadjuvant Therapy Stage II Gastric Cancer AJCC v8 | View |
| None | Postneoadjuvant Therapy Stage III Gastric Cancer AJCC v8 | View |
Keywords: